Suchergebnisse - "Castagna, Luca"

PubPharm (11)

1

Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis : A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)

enthalten in: American journal of hematology | 2021

von Polverelli, N. | Mauff, K. | Kröger, N. | +26

CommentIn: Am J Hematol. 2021 Jan;96(1):12-13. - PMID 33219701

2

Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission : A Report From the EBMT Acute Leukemia Working Party

enthalten in: Clinical lymphoma, myeloma & leukemia | 2020

von El-Cheikh, J. | Labopin, M. | Al-Chami, F. | +12

3

The efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100 mg/m(2) intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-risk myelodysplastic syndrome or acute leukemia

enthalten in: Leukemia & lymphoma | 2016

von Wanquet, A. | Crocchiolo, R. | Furst, S. | +12

4

National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen

enthalten in: Leukemia & lymphoma | 2014

von Saillard, C. | Crocchiolo, R. | Furst, S. | +9

5

Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2014

von Devillier, R. | Fürst, S. | El-Cheikh, J. | +16

6

A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor

enthalten in: American journal of hematology | 2014

von Devillier, R. | Fürst, S. | Crocchiolo, R. | +16

7

Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseases

enthalten in: Cancer | 2013

von Crocchiolo, R. | Esterni, B. | Castagna, L. | +10

8

Do different conditioning regimens really make a difference?

enthalten in: Hematology. American Society of Hematology. Education Program | 2012

von Blaise, D. | Castagna, L.

9

Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies

enthalten in: Experimental hematology | 2010

von Blaise, D. | Farnault, L. | Faucher, C. | +14

10

Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults : a retrospective analysis of the European Group for Blood and Marrow Transplantation

enthalten in: Haematologica | 2007

von Secondino, S. | Carrabba, M. | Pedrazzoli, P. | +10